Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The full Update will be available as a PDF on our website(external link) 

The changes will be published in the online HML around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

Pharmaceutical

Change

Atomoxetine (APO-Atomoxetine) cap 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg

New listings

  • cap 10 mg (p’code 2632497)
  • cap 18 mg (p’code 2637065)
  • cap 25 mg (p’code 2637073)
  • cap 40 mg (p’code 2637081)
  • cap 60 mg (p’code 2636050)
  • cap 80 mg (p’code 2632500)
  • cap 100 mg (p’code 2632519)

Celecoxib (Celecoxib Pfizer) cap 100 mg and 200 mg

price decrease and addition of PSS

Clonidine hydrochloride (Clonidine Teva) tab 25 mcg

price decrease and addition of PSS

Clonidine hydrochloride (Clonidine BNM) tab 25 mcg

to be delisted 1 November 2022

Docusate sodium with sennosides (Laxsol) tab 50 mg with sennosides 8 mg 

price decrease and addition of PSS

Eftrenocog alfa [Recombinant factor IX] (Alprolix) inj 4,000 iu vial

new listing (p’code 2636069)

Eplerenone (Inspra) tab 25 mg

new Pharmacode listing (p’code 2619512)

Fluoxetine hydrochloride (Fluox) tab dispersible 20 mg, scored, 28 tab

new pack size listing (p’code 2618575)

High protein enteral feed 1.28 kcal/ml (e.g. Nutrison Protein Plus Multi Fibre) liquid 6.3 g protein, 14.1 g carbohydrate, 4.9 g fat and 1.5 g fibre per 100 ml, 1,000 ml bottle

new listing

High protein enteral feed 1.28 kcal/ml (e.g. Nutrison Protein Plus Multi Fibre) liquid 6.3 g protein, 14.1 g carbohydrate, 4.9 g fat and 1.5 g fibre per 100 ml, 1,000 ml bag

to be delisted 1 June 2023

High protein oral feed 2.4 kcal/ml (e.g. Fortisip Compact Protein) liquid 14.6 g protein, 25.3 g carbohydrate and 9.6 g fat per 100 ml, 125 ml bottle 

delisting delayed until 1 December 2022

Hydroxocobalamin inj 1 mg per ml,
1 ml ampoule

Brand change

  • Hydroxocobalamin Panpharma – new listing and addition of PSS (p’code 2637391)

Neo-B12 to be delisted 1 November 2022

Iodixanol (Visipaque)

  • inj 270 mg per ml (iodine equivalent), 50 ml and 100 ml bottle
  • inj 320 mg per ml (iodine equivalent), 50 ml, 100 ml and 200 ml bottle

price increase

Iohexol (Omnipaque)

  • inj 240 mg per ml (iodine equivalent), 50 ml bottle
  • inj 300 mg per ml (iodine equivalent), 20 ml, 50 ml and 100 ml bottle
  • inj 350 mg per ml (iodine equivalent), 20 ml, 50 ml, 75 ml, 100 ml and 200 ml bottle

price increase

Lidocaine [lignocaine] hydrochloride (Lidocaine-Baxter) inj 1%, 20 ml vial 

new listing (p’code 2599856)

Magnesium sulphate inj 100 mg per ml, 40 ml bag

new presentation listing

Palivizumab (Synagis) inj 100 mg per ml, 1 ml vial

new listing (p’code 2621835)

Paracetamol (Biomed) suppos 25 mg and 50 mg

to be delisted 1 June 2023

Peptide-based enteral feed 1 kcal/ml (e.g. Nutrison Advanced Peptisorb) liquid 4 g protein, 17.7 g carbohydrate and 1.7 g fat per 100 ml, 1,000 ml bottle 

new listing

Peptide-based enteral feed 1 kcal/ml (e.g. Nutrison Advanced Peptisorb) liquid 4 g protein, 17.7 g carbohydrate and 1.7 g fat per 100 ml, 1,000 ml bag 

to be delisted 1 June 2023